Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91,628 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers.
Zhang C, Wang Z, Yang Z, Wang M, Li S, Li Y, Zhang R, Xiong Z, Wei Z, Shen J, Luo Y, Zhang Q, Liu L, Qin H, Liu W, Wu F, Chen W, Pan F, Zhang X, Bie P, Liang H, Pecher G, Qian C. Zhang C, et al. Among authors: li s, li y. Mol Ther. 2017 May 3;25(5):1248-1258. doi: 10.1016/j.ymthe.2017.03.010. Epub 2017 Mar 31. Mol Ther. 2017. PMID: 28366766 Free PMC article. Clinical Trial.
Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB.
Li S, Zhang J, Wang M, Fu G, Li Y, Pei L, Xiong Z, Qin D, Zhang R, Tian X, Wei Z, Chen R, Chen X, Wan J, Chen J, Wei X, Xu Y, Zhang P, Wang P, Peng X, Yang S, Shen J, Yang Z, Chen J, Qian C. Li S, et al. Among authors: li y. Br J Haematol. 2018 May;181(3):360-371. doi: 10.1111/bjh.15195. Epub 2018 Apr 10. Br J Haematol. 2018. PMID: 29637550 Free article. Clinical Trial.
Donor-derived CAR-T Cells Serve as a Reduced-intensity Conditioning Regimen for Haploidentical Stem Cell Transplantation in Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.
Zhang C, Kong PY, Li S, Chen T, Ni X, Li Y, Wang M, Liu Y, Gao L, Gao L, Peng XG, Sun AH, Wang P, Yang Z, Zhang X, Qian C. Zhang C, et al. Among authors: li s, li y. J Immunother. 2018 Jul/Aug;41(6):306-311. doi: 10.1097/CJI.0000000000000233. J Immunother. 2018. PMID: 29864079 Review.
Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia.
Heng G, Jia J, Li S, Fu G, Wang M, Qin D, Li Y, Pei L, Tian X, Zhang J, Wu Y, Xiang S, Wan J, Zhu W, Zhang P, Zhang Q, Peng X, Wang L, Wang P, Wei Z, Zhang Y, Wang G, Chen X, Zhang C, Sun Y, Zhao W, Fan Y, Yang Z, Chen J, Qian C. Heng G, et al. Among authors: li s, li y. Clin Cancer Res. 2020 Apr 1;26(7):1606-1615. doi: 10.1158/1078-0432.CCR-19-1339. Epub 2019 Nov 15. Clin Cancer Res. 2020. PMID: 31732519 Clinical Trial.
Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management.
Li S, Wang X, Yuan Z, Liu L, Luo L, Li Y, Wu K, Liu J, Yang C, Li Z, Wang D, Shen L, Ye X, He J, Han C, Wang Y, Zhang D, Dong Y, Fang L, Chen Y, Sersch M, Cao WW, Wang S. Li S, et al. Among authors: li y, li z. Clin Cancer Res. 2021 Mar 1;27(5):1242-1246. doi: 10.1158/1078-0432.CCR-20-1271. Epub 2020 Nov 24. Clin Cancer Res. 2021. PMID: 33234511
Acetylation and deacetylation in cancer stem-like cells.
Liu N, Li S, Wu N, Cho KS. Liu N, et al. Among authors: li s. Oncotarget. 2017 Jul 11;8(51):89315-89325. doi: 10.18632/oncotarget.19167. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179522 Free PMC article. Review.
91,628 results
You have reached the last available page of results. Please see the User Guide for more information.